ALS is a consulting services business based in Australia. ALS shares (ALQ) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. ALS has a trailing 12-month revenue of around $2.4 billion. If you're looking to buy shares, check out the steps below.
To buy shares listed in Australia such as ALS, you'll need to sign up to a broker with access to the ASX. Our table can help you compare share trading platforms and choose. Then follow these steps.
Our top pick for
Best for beginner
Our top pick for
Education & learning
Our top pick for
Australian stocks
| 52-week range | $10.3513 - $13.81 |
|---|---|
| 50-day moving average | $12.7398 |
| 200-day moving average | $12.0521 |
| Target price | $13.27 |
| PE ratio | 24.3148 |
| Dividend yield | $0.39 (2.99%) |
| Earnings per share (TTM) | $0.54 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$13.13
| 1 week (2024-04-11) | -2.23% |
|---|---|
| 1 month (2024-03-18) | 0.69% |
| 3 months (2024-01-18) | 5.89% |
| 6 months (2023-10-18) | 16.81% |
| 1 year (2023-04-18) | 0.61% |
|---|---|
| 2 years (2022-04-14) | 0.38% |
| 3 years (2021-04-16) | 29.62% |
| 5 years (2019-04-18) | 62.30% |
Valuing ALS stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of ALS's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
ALS's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, ALS shares trade at around 24x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
ALS's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.12. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into ALS's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
ALS's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $576.1 million (£0.0 million).
The EBITDA is a measure of a ALS's overall financial performance and is widely used to measure stock profitability.
| Revenue TTM | $2.4 billion |
|---|---|
| Operating margin TTM | 19.16% |
| Gross profit TTM | $752.8 million |
| Return on assets TTM | 8.67% |
| Return on equity TTM | 19.5% |
| Profit margin | 11.66% |
| Book value | 2.933 |
| Market capitalisation | $6.4 billion |
TTM: trailing 12 months
Dividend payout ratio: 120.89% of net profits
Recently ALS has paid out, on average, around 120.89% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.99% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), ALS shareholders could enjoy a 2.99% return on their shares, in the form of dividend payments. In ALS's case, that would currently equate to about A$0.39 per share.
ALS's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 22 November 2023 (the "ex-dividend date").
ALS's shares were split on a 5:1 basis on 1 August 2012. So if you had owned 1 share the day before the split, the next day you would own 5 shares. This wouldn't directly have changed the overall worth of your ALS shares – just the quantity. However, indirectly, the new 80% lower share price could have impacted the market appetite for ALS shares which in turn could have impacted ALS's share price.
Over the last 12 months, ALS's shares have ranged in value from as little as $10.3513 up to $13.81. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while ALS's is 1.156. This would suggest that ALS's shares are a little bit more volatile than the average for this exchange and represent, relatively speaking, a slightly higher risk (but potentially also market-beating returns).
ALS Limited provides professional technical services primarily in the areas of testing, measurement, and inspection in Africa, Asia/Pacific, Europe, the Middle East, and the Americas. The company operates through Commodities and Life Sciences segments. The Commodities segment offers assaying and analytical testing, and metallurgical services for the mining and mineral exploration companies. Its testing and consulting services cover the resource life cycle, including exploration, feasibility, optimization, production, design, development, trade, and rehabilitation. This segment also provides coal sampling, analysis and certification, formation evaluation, and related analytical testing services. The Life Sciences segment offers analytical testing and sampling, and remote monitoring services for the environmental, food, pharmaceutical, and consumer products markets; and microbiological, physical, and chemical testing services. This segment provides analytical testing data to assist consulting and engineering firms, industries, and governments. ALS Limited was founded in 1863 and is headquartered in Milton, Australia.
AMP Ltd Preferred
AUD104.84
ANZ Group Holdings Ltd. Pfd.
AUD103.62
Challenger Ltd Preferred
AUD104.97
Macquarie Bank Ltd Pref
AUD105.41
Macquarie Group Ltd Pref C
AUD103.54
Macquarie Group Ltd Pref
AUD105.12
Macquarie Group Preferred
AUD102.64
Macquarie Group Limited
AUD105.53
Suncorp Group Ltd Pref
AUD101.41
Westpac Banking Corp Pref
AUD102.82
Everything we know about the Tasmea Limited IPO, plus information on how to buy in.
Steps to owning and managing Blinklab shares.
Everything we know about the Maverick Minerals IPO, plus information on how to buy in.
Steps to owning and managing Far Northern Resources shares.
Commodity ETFs can be used to hedge against inflation. Here's what they do, why they should be on your watchlist and how they can help your portfolio.
Looking for the best performing stocks in Australia? We update this list weekly.
Steps to owning and managing Gol Linhas Aéreas Inteligentes SA shares from Australia.
Trade ASX stocks and ETFs with a $2 brokerage fee and a low minimum investment of just $10.
These ETFs have the lowest fees on the market, but does that make them the best?
You've heard of CommSec but how does it stack up to the likes of IG, CMC Invest and other players in the market?